The Main Ingredient in Psychedelic Mushrooms Is Closer to Becoming an FDA-Approved Depression Treatm

Gizmodo ---------- The active ingredient that makes magic mushrooms so magic—the psychedelic drug psilocybin—is one step closer to becoming a legal treatment for difficult cases of depression. This week, the company Compass Pathways announced that it had received the Food and Drug Administration’s Breakthrough Therapy designation for its psilocybin-based treatment. The designation will fast track the FDA’s review of the treatment for possible approval. To learn more click on the picture below to read the article.